Background
For several years, Elion has partnered with a New Zealand healthcare agency to support their oncology client – one of the world’s leading pharmaceutical companies – with the delivery of high-quality advisory board reports.
These aren’t just meeting minutes. Advisory boards bring together key opinion leaders, healthcare professionals and patient voices to collate insights that influence real-world practice, product strategy and market access decisions. Accurately capturing the conversation and extracting what really matters is a critical and highly strategic task and one that requires scientific expertise, editorial judgement and a deep understanding of the therapy area.
The Brief
Advisory boards are designed to explore the issues that truly shape patient care, from prescribing behaviours and regional variations in practice to access barriers and cultural considerations. For this client, the focus was on oncology, with the aim of identifying insights that would inform both their current portfolio and their pipeline strategy.
The agency needed a partner who could:
- attend and closely follow the discussion – in person or virtually
- identify the key themes, challenges and opportunities
- deliver a report that is well-structured, clear, credible and immediately useful.
Our Solution
An Elion medical writer attends each advisory board, working alongside our agency partner to provide both editorial expertise and therapeutic knowledge. We capture detailed notes in real time and use AI-powered transcription tools (our preferred tool is Otter.ai) as a secondary reference.
But our value goes far beyond note taking. Our writers are skilled at distilling complex conversations, synthesising diverse perspectives and producing reports that support strategic decision-making from market access planning to internal cross-functional alignment.
With deep oncology experience, we’re not just documenting the discussion, we’re contributing to it by recognising key innovations, clinical trends and unmet needs as they emerge.
Outcomes
A strong, trusted parternship
Our consistent quality and ability to add value has led to ongoing engagement with both the agency and their pharma client, reflecting their trust, our reliability and the strength of the partnership.
Strategic reporting that guides action
Our reports provide actionable insights that inform internal planning, shape communications and support registration and funding discussions.
Optimised use of skills
Our agency partner trusts Elion to take full ownership of advisory board reporting, from attending the meeting to delivering high-quality outputs, which frees internal teams to focus on client service and strategic delivery.
Looking ahead
As the need for expert-led, insight-rich reporting grows, Elion remains a trusted partner for agencies and pharmaceutical clients alike.
Our flexible, knowledgeable team helps clients move from conversation to clarity, capturing what matters and delivering content that drives action.
